Suxing (Sue) Liu, PhD
Dr Liu joined EBI in March 2016 as the Head of Biology. Sue has over 14 years of drug discovery experience in global pharmaceutical companies, such as, Schering-Plough, Merck and AstraZeneca with increased responsibilities. Over her career, Sue nominated three pre-clinical candidates for clinical development.
Prior to joining EBI, Sue was Director of Corporate Development in GenScript Biotech Corp. Piscataway, New Jersey. In this capacity, she in-licensed new technologies to improve capability of R&D and had business impact greater than $6M/year.
Sue published over 30 peer-reviewed research articles and patent applications, including several book chapters and review articles.
Sue received her Ph.D. in Biochemistry from the University of Maryland at College Park, under the guidance of Professor Richard N. Armstrong (Editor-in-chief of Biochemistry). She did her postdoctoral fellowship at Schering-Plough Research Institute mentored by Dr Cecil B. Pickett (former President of Schering-Plough Research Institute and Biogen-Idec, and Member of the Institute of Medicine of National Academy of Sciences).